M&A Deal Summary

Supernus Pharmaceuticals Acquires Adamas

On October 11, 2021, Supernus Pharmaceuticals acquired life science company Adamas for 450M USD

Acquisition Highlights
  • This is Supernus Pharmaceuticals’ 3rd transaction in the Life Science sector.
  • This is Supernus Pharmaceuticals’ largest (disclosed) transaction.
  • This is Supernus Pharmaceuticals’ 3rd transaction in the United States.
  • This is Supernus Pharmaceuticals’ 1st transaction in California.

M&A Deal Summary
Date 2021-10-11
Target Adamas
Sector Life Science
Buyer(s) Supernus Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 450M USD
Advisor(s) Lazard Ltd. (Financial)
Cooley (Legal)

Target

Adamas

Emeryville, California, United States
Adamas is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system (CNS). Its achieve this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products. Adamas was founded in 2000 and is based in Emeryville, California.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Supernus Pharmaceuticals

Rockville, Maryland, United States
Category Company
Founded 2005
Sector Life Science
Employees652
Revenue 608M USD (2023)
DESCRIPTION

Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders. Supernus Pharmaceuticals was founded in 2005 and is based in Rockville, Maryland.

DEAL STATS #
Overall 3 of 3
Sector (Life Science) 3 of 3
Type (Add-on Acquisition) 2 of 2
State (California) 1 of 1
Country (United States) 3 of 3
Year (2021) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-09 US WorldMeds - CNS Portfolio

Kentucky, United States

US WorldMeds LLC - CNS Portfolio (central nervous system) is involved in developing and commercializing products for the treatment of Parkinson’s disease.

Buy -
Mergr

Product

Company

Legal